The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE‐DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)

BACKGROUND: The RE‐DUAL PCI trial demonstrated that in patients with nonvalvular atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), dual therapy with dabigatran and a P2Y(12) inhibitor, either clopidogrel or ticagrelor, reduced the risk of bleeding without an increased ris...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Eccleston, David S., Kim, Joseph M., ten Berg, Jurien M., Steg, P. Gabriel, Bhatt, Deepak L., Hohnloser, Stefan H., de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory Y. H., Oldgren, Jonas, Cannon, Christopher P.
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2021
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259156/
https://ncbi.nlm.nih.gov/pubmed/34042199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23649
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars